A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)
Clinical trial NCT04993768 · COMPLETED
Trial details
- NCT number
- NCT04993768
- Sponsor
- Transposon Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-12
- Primary completion
- 2024-02-24
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.